MARKET

VEEV

VEEV

Veeva Systems
NYSE

Real-time Quotes | Nasdaq Last Sale

220.86
+3.70
+1.70%
Opening 09:40 01/27 EST
OPEN
219.82
PREV CLOSE
217.16
HIGH
222.42
LOW
219.82
VOLUME
27.73K
TURNOVER
--
52 WEEK HIGH
343.96
52 WEEK LOW
214.56
MARKET CAP
33.96B
P/E (TTM)
73.42
1D
5D
1M
3M
1Y
5Y
Van Eck Associates Corp Buys MercadoLibre Inc, The Walt Disney Co, Broadcom Inc, Sells Taiwan ...
New York, NY, based Investment company Van Eck Associates Corp (Current Portfolio) buys MercadoLibre Inc, The Walt Disney Co, Broadcom Inc, Emerson Electric Co, Equifax Inc, sells Taiwan Semiconductor Manufacturing Co, NVIDIA Corp, Pfizer Inc, Thermo Fishe...
GuruFocus.com · 12h ago
Should You Still Invest in Veeva Systems (VEEV)?
Baron Funds, an asset management firm, published its “Baron Asset Fund” fourth quarter 2021 investor letter – a copy of which can be downloaded here. Against this backdrop, Baron Asset Fund (the “Fund”) gained 5.04% (Institutional Shares), while the Russel...
Insider Monkey · 1d ago
Veeva Systems (VEEV)-LYSARC Partner to Advance Lymphoma Therapy
Veeva Systems' (VEEV) Veeva Development Cloud will allow LYSARC to develop innovative lymphoma therapies or enhance current therapies.
Zacks · 1d ago
Cfm Wealth Partners Llc Buys Axcelis Technologies Inc, Tenable Holdings Inc, KKR Inc, Sells ...
Investment company Cfm Wealth Partners Llc (Current Portfolio) buys Axcelis Technologies Inc, Tenable Holdings Inc, KKR Inc, Jamf Holding Corp, Jamf Holding Corp, sells Contango Oil & Gas Co, Teladoc Health Inc, DraftKings Inc, CoStar Group Inc, Veeva Syst...
GuruFocus.com · 5d ago
Veeva-LYSARC team up on innovation for lymphoma treatments
Veeva Systems (NYSE:VEEV) said the Lymphoma Academic Research Organization (LYSARC) selected Veeva Development Cloud to improve operational efficiency across its lymphoma therapy research. LYSARC will use applications in Vault Clinical,
Seekingalpha · 01/20 13:12
Veeva Systems Announces The Lymphoma Academic Research Organization Selected Veeva Development Cloud To Improve Operational Efficiency Across Its Lymphoma Therapy Research
Veeva Systems (NYSE:VEEV) today announced that the Lymphoma Academic Research Organization (LYSARC) selected Veeva Development Cloud to improve operational efficiency across its lymphoma therapy research. LYSARC will use
Benzinga · 01/20 12:05
LYSARC Partners with Veeva to Accelerate Innovation for Lymphoma Treatments
Veeva Systems (NYSE: VEEV) today announced that the Lymphoma Academic Research Organization (LYSARC) selected Veeva Development Cloud to improve operational efficiency across its lymphoma therapy research. LYSARC will use applications in Vault Clinical, Va...
PR Newswire · 01/20 12:03
Jim Cramer Shares His Thoughts On T-Mobile, Veeva Systems And More
On CNBC’s "Mad Money Lightning Round," Jim Cramer said although he likes Wheels Up Experience Inc. (NYSE: UP) CEO Kenny Dichter very much, he will not recommend SPACs unless they're profitable.
Benzinga · 01/19 12:03
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of VEEV. Analyze the recent business situations of Veeva Systems through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 23 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

30.43%Strong Buy
34.78%Buy
30.43%Hold
4.35%Under-perform
0.00%Sell
Analyst Price Target
The average VEEV stock price target is 317.57 with a high estimate of 400.00 and a low estimate of 275.00.
High400.00
Average317.57
Low275.00
Current 220.86
EPS
Actual
Estimate
0.240.480.730.97
Q4 2021
Q1 2022
Q2 2022
Q3 2022
Q4 2022
Institutional Holdings
Institutions: 1.08K
Institutional Holdings: 133.36M
% Owned: 86.73%
Shares Outstanding: 153.76M
TypeInstitutionsShares
Increased
327
7.77M
New
77
729.35K
Decreased
247
6.48M
Sold Out
67
382.08K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+0.32%
Healthcare Equipment & Supplies
+0.70%
Key Executives
Non-Executive Chairman/Independent Director
Gordon Ritter
President/Chief Operating Officer
Thomas Schwenger
Chief Executive Officer
Peter Gassner
Chief Financial Officer
Brent Bowman
Executive Vice President/Director of Sales
Alan Mateo
Senior Vice President/General Counsel/Secretary
Jonathan Faddis
Senior Vice President
Frederic Lequient
Chief Marketing Officer
E. Nitsa Zuppas
Director
Timothy Cabral
Director
Priscilla Hung
Director
Tina Hunt
Director
Marshall Mohr
Director
Matthew Wallach
Independent Director
Ronald Codd
No Data
About VEEV
Veeva Systems Inc. (Veeva) is a provider of Industry cloud-based software solutions for the global life sciences industry. The Company's solutions include cloud software, data, and business consulting that are designed to meet the needs of its customers and their strategic business functions, from research and development (R&D) to commercialization. Its industry cloud solutions for the life sciences industry are grouped into two product areas: Veeva Commercial Cloud and Veeva Vault. Veeva Commercial Cloud offers various software, data and analytics solutions. Its Cloud software applications include Veeva CRM and Veeva Medical CRM, Veeva CRM MyInsights, Veeva Align, Veeva CLM and Veeva CRM Events Management. Its data and analytics solutions include Veeva OpenData, Veeva Link, Veeva Crossix, Veeva Data Cloud and Veeva Nitro. Veeva Vault offers various cloud-based, enterprise content and data management applications, which includes Veeva Vault eTMF and Veeva Vault MedComms.

Webull offers kinds of Veeva Systems Inc stock information, including NYSE:VEEV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VEEV stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading VEEV stock methods without spending real money on the virtual paper trading platform.